Stable pulmonary function after haploidentical stem cell transplantation with post-transplant cyclophosphamide: a single center experience

被引：0
作者：
Paviglianiti, Annalisa [1 ,2 ]
Sestili, Simona [1 ]
Bianchessi, Antonio [1 ,3 ,4 ]
Memoli, Mara [1 ,5 ]
Dulery, Remy [1 ]
Banet, Anne [1 ]
Van De Wyngaert, Zoe [1 ]
Belhocine, Ramdane [1 ]
Ledraa, Tounes [1 ]
Malard, Florent [1 ]
Mohty, Mohamad [1 ]
Brissot, Eolia [1 ]
机构：
[1] Sorbonne Univ, Serv Hematol Clin & Therapie Cellulaire, Hop St Antoine, 184 Rue Faubourg St Antoine, F-75012 Paris, France
[2] Univ Campus Biomed, Rome, Italy
[3] Univ Pavia, Dept Mol Med, Pavia, Italy
[4] Fdn IRCCS Policlin San Matteo, Div Hematol, Pavia, Italy
[5] Univ Naples Federico II, Hematol & Hematopoiet Stem Cell Transplant Ctr, Dept Med & Surg, Naples, Italy
来源：
LEUKEMIA & LYMPHOMA | 2022年 / 63卷 / 02期
关键词：
PFT; HAPLO; pulmonary function; pulmonary function tests; HSCT; lung function score; BRONCHIOLITIS-OBLITERANS; LUNG-FUNCTION; COMPLICATIONS; DISEASE; ABNORMALITIES; MORTALITY; PREVENTS; INDEX;
D O I：
10.1080/10428194.2021.1984460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Prior studies have reported pulmonary function tests (PFT) before and after related and unrelated allogeneic hematopoietic stem cell transplantation (HSCT). However, limited data exist on the evaluation of lung function after haploidentical stem cell transplantation (HAPLO) with post-transplant cyclophosphamide (PTCY). We retrospectively reported the evaluation of PFTs at screening before HAPLO in 80 patients at 100 days and 1 year of follow-up. The proportion of surviving patients with available PFTs at 100 days and 1 year were 86% and 68%, respectively. During the follow-up period, four patients met the criteria for bronchiolitis obliterans syndrome and two for interstitial lung disease. Overall survival was 73% (95% CI 62-82%) at 2 years. We observed a significant reduction in diffusing capacity of the lungs for carbon monoxide (DLCO) corrected for the most recent hemoglobin concentration (DLCOc) at 100 days after HAPLO. However, an overall substantial stable pulmonary function was observed at 1 year.
引用
收藏
页码：443 / 449
页数：7
相关论文
共 30 条
[1]   Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation [J].
Ahn, Jee Hwan ;
Jo, Kyung-Wook ;
Song, Jin Woo ;
Shim, Tae Sun ;
Lee, Sei Won ;
Lee, Jae Seung ;
Kim, Dae-Young ;
Lee, Je-Hwan ;
Lee, Jung-Hee ;
Choi, Yunsuk ;
Lee, Kyoo-Hyung .
CLINICAL TRANSPLANTATION, 2015, 29 (12) :1133-1139
[2]   Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation [J].
Armand, Philippe ;
Kim, Haesook T. ;
Logan, Brent R. ;
Wang, Zhiwei ;
Alyea, Edwin P. ;
Kalaycio, Matt E. ;
Maziarz, Richard T. ;
Antin, Joseph H. ;
Soiffer, Robert J. ;
Weisdorf, Daniel J. ;
Rizzo, J. Douglas ;
Horowitz, Mary M. ;
Saber, Wael .
BLOOD, 2014, 123 (23) :3664-3671
[3]   Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: Long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation [J].
Bacigalupo, A ;
Lamparelli, T ;
Barisione, G ;
Bruzzi, P ;
Guidi, S ;
Alessandrino, PE ;
di Bartolomeo, P ;
Oneto, R ;
Bruno, B ;
Sacchi, N ;
van Lint, MT ;
Bosi, A .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (05) :560-565
[4]   Defining the Intensity of Conditioning Regimens: Working Definitions [J].
Bacigalupo, Andrea ;
Ballen, Karen ;
Rizzo, Doug ;
Giralt, Sergio ;
Lazarus, Hillard ;
Ho, Vincent ;
Apperley, Jane ;
Slavin, Shimon ;
Pasquini, Marcelo ;
Sandmaier, Brenda M. ;
Barrett, John ;
Blaise, Didier ;
Lowski, Robert ;
Horowitz, Mary .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (12) :1628-1633
[5]  
BADIER M, 1993, BONE MARROW TRANSPL, V12, P457
[6]   Carbon Monoxide Diffusion Capacity: How Low Can You Go for Hematopoietic Cell Transplantation Eligibility? [J].
Chien, Jason W. ;
Sullivan, Keith M. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (04) :447-453
[7]   Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation [J].
Chien, JW ;
Maris, MB ;
Sandmaier, BM ;
Maloney, DG ;
Storb, RF ;
Clark, JG .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (04) :288-296
[8]   PREDICTIVE VALUE OF PULMONARY-FUNCTION TESTS BEFORE MARROW TRANSPLANTATION [J].
CRAWFORD, SW ;
FISHER, L .
CHEST, 1992, 101 (05) :1257-1264
[9]   Stable long-term pulmonary function after fludarabine, antithymocyte globulin and i.v. BU for reduced-intensity conditioning allogeneic SCT [J].
Dirou, S. ;
Malard, F. ;
Chambellan, A. ;
Chevallier, P. ;
Germaud, P. ;
Guillaume, T. ;
Delaunay, J. ;
Moreau, P. ;
Delasalle, B. ;
Lemarchand, P. ;
Mohty, M. .
BONE MARROW TRANSPLANTATION, 2014, 49 (05) :622-627
[10]   T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors [J].
Ditschkowski, Markus ;
Elmaagacli, Ahmet H. ;
Trenschel, Rudolf ;
Peceny, Rudolf ;
Koldehoff, Michael ;
Schulte, Claudia ;
Beelen, Dietrich W. .
HAEMATOLOGICA, 2007, 92 (04) :558-561
123